Regulation of non-classical FGF1 release and FGF-dependent cell transformation by CBF1-mediated notch signaling

Journal of Cellular Physiology

Volumn 226, Issue 11, 2011, Pages 3064-3075

  Kacer, Doreen ^a   Mcintire, Christian ^a   Kirov, Alek ^a   Kany, Erin ^a   Roth, Jennifer ^a   Liaw, Lucy ^a   Small, Deena ^b   Friesel, Robert ^a   Basilico, Claudio ^c   Tarantini, Francesca ^d   Verdi, Joseph ^a   Prudovsky, Igor ^a  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; NOTCH RECEPTOR; NUCLEAR PROTEIN; NUCLEAR PROTEIN MAMLI; SPHINGOSINE KINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CBFI; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CHICKEN; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENETIC REGULATION; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLAST GROWTH FACTOR 1; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MELANOMA; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; NUCLEAR PROTEINS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, NOTCH; S100 PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION;

MUS MUSCULUS;

EID: 80051916750     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22663     Document Type: Article

References (46)

1. Chung CN, Hamaguchi Y, Honjo T, Kawaichi M. 1994. Site-directed mutagenesis study on DNA binding regions of the mouse homologue of Suppressor of Hairless, RBP-J kappa. Nucleic Acids Res 22: 2938-2944.
2. Demehri S, Turkoz A, Kopan R. 2009. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16: 55-66.
3. Di Serio C, Doria L, Pellerito S, Prudovsky I, Micucci I, Massi D, Landriscina M, Marchionni N, Masotti G, Tarantini F. 2008. The release of fibroblast growth factor-1 from melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-kinase/Akt intracellular signaling pathway. Cancer Lett 267: 67-74.
4. Djalilian AR, Namavari A, Ito A, Balali S, Afshar A, Lavker RM, Yue BY. 2008. Down-regulation of Notch signaling during corneal epithelial proliferation. Mol Vis 14: 1041-1049.
5. Duarte M, Kolev V, Kacer D, Mouta-Bellum C, Soldi R, Graziani I, Kirov A, Friesel R, Liaw L, Small D, Verdi J, Maciag T, Prudovsky I. 2008. Novel cross-talk between three cardiovascular regulators: Thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release. Mol Biol Cell 19: 4863-4874.
6. Forough R, Xi Z, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, Maciag T. 1993. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J Biol Chem 268: 2960-2968.
7. Fortini ME. 2009. Notch signaling: The core pathway and its posttranslational regulation. Dev Cell 16: 633-647.
8. Gridley T. 2007. Notch signaling in vascular development and physiology. Development 134: 2709-2718.
9. Hanlon L, Avila JL, Demarest RM, Troutman S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V, Long F, Capobianco AJ, Kissil JL. 2010. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res 70: 4280-4286.
10. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71: 1842-1849.
11. Hirai Y, Nelson CM, Yamazaki K, Takebe K, Przybylo J, Madden B, Radisky DC. 2007. Non-classical export of epimorphin and its adhesion to {alpha}v-integrin in regulation of epithelial morphogenesis. J Cell Sci 120: 2032-2043.
12. Jackson A, Friedman S, Zhan K, Engleka KA, Forough R, Maciag T. 1992. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci 89: 10691-10695.
13. Katoh M. 2007. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 3: 30-38.
14. Kolev V, Mandinova A, Guinea-Viniegra J, Hu B, Lefort K, Lambertini C, Neel V, Dummer R, Wagner EF, Dotto GP. 2008. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 10: 902-911.
15. Kwabi-Addo B, Ozen M, Ittmann M. 2004. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 11: 709-724.
16. Landriscina M, Soldi R, Bagala C, Micucci I, Bellum S, Tarantini F, Prudovsky I, Maciag T. 2001. S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J Biol Chem 276: 22544-22552.
17. LaVallee TM, Tarantini F, Gamble S, Carreira CM, Jackson A, Maciag T. 1998. Synaptotagmin-1 is required for fibroblast growth factor-1 release. J Biol Chem 273: 22217-22223.
18. Leong KG, Karsan A. 2006. Recent insights into the role of Notch signaling in tumorigenesis. Blood 107: 2223-2233.
19. Liu ZJ, Xiao M, Balint K, Soma A, Pinnix CC, Capobianco AJ, Velazquez OC, Herlyn M. 2006. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J 20: 1009-1011.
20. Mandinova A, Soldi R, Graziani I, Bagala C, Bellum S, Landriscina M, Tarantini F, Prudovsky I, Maciag T. 2003. S100A13 mediates the copper-dependent stress-induced release of IL-1{alpha} from both human U937 and murine NIH 3T3 cells. J Cell Sci 116: 2687-2696.
21. Massi D, Landriscina M, Piscazzi A, Cosci E, Kirov A, Paglierani M, Di Serio C, Mourmouras V, Fumagalli S, Biagioli M, Prudovsky I, Miracco C, Santucci M, Marchionni N, Tarantini F. 2010. S100A13 is a new angiogenic marker in human melanoma. Mod Pathol 23: 804-813.
22. Matsunaga H, Ueda H. 2010. Stress-induced non-vesicular release of prothymosin-alpha initiated by an interaction with S100A13 and its blockade by caspase-3 cleavage. Cell Death Differ 17: 1760-1772.
23. Miller DL, Ortega S, Bashayan O, Basch R, Basilico C. 2000. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol 20: 2260-2268.
24. Neilson KM, Friesel RE. 1995. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J Biol Chem 270: 26037-26040.
25. Nickel W. 2005. Unconventional secretory routes: Direct protein export across the plasma membrane of mammalian cells. Traffic 6: 607-614.
26. Nickel W, Rabouille C. 2009. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10: 148-155.
27. Nofziger D, Miyamoto A, Lyons KM, Weinmaster G. 1999. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126: 1689-1702.
28. Okunieff P, Fenton BM, Zhang L, Kern FG, Wu T, Greg JR, Ding I. 2003. Fibroblast growth factors (FGFS) increase breast tumor growth rate, metastases, blood flow, and oxygenation without significant change in vascular density. Adv Exp Med Biol 530: 593-601.
29. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2: online publication.
30. Perumalsamy LR, Nagala M, Sarin A. 2010. Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival. Proc Natl Acad Sci USA 107: 6882-6887.
31. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. 2005. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178.
32. Proweller A, Tu L, Lepore JJ, Cheng L, Lu MM, Seykora J, Millar SE, Pear WS, Parmacek MS. 2006. Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 66: 7438-7444.
33. Prudovsky I, Tarantini F, Landriscina M, Neivandt D, Soldi R, Kirov A, Small D, Kathir KM, Rajalingam D, Kumar TK. 2008. Secretion without Golgi. J Cell Biochem 103: 1327-1343.
34. Renaud F, Desset S, Oliver L, Gimenez-Gallego G, Van Obberghen E, Courtois Y, Laurent M. 1996. The neurotrophic activity of fibroblast growth factor 1 (FGF1) depends on endogenous FGF1 expression and is independent of the mitogen-activated protein kinase cascade pathway. J Biol Chem 271: 2801-2811.
35. Sahlgren C, Lendahl U. 2006. Notch signaling and its integration with other signaling mechanisms. Regen Med 1: 195-205.
36. Sanalkumar R, Dhanesh SB, James J. 2010. Non-canonical activation of Notch signaling/target genes in vertebrates. Cell Mol Life Sci.
37. Sanalkumar R, Indulekha CL, Divya TS, Divya MS, Anto RJ, Vinod B, Vidyanand S, Jagatha B, Venugopal S, James J. 2010a. ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes-1 expression and synergistically activates the expression of Hes-1 in Notch-dependent neural progenitors. J Neurochem 113: 807-818.
38. Shih Ie M, Wang TL. 2007. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res 67: 1879-1882.
39. Small D, Kovalenko D, Kacer D, Liaw L, Landriscina M, Di Serio C, Prudovsky I, Maciag T. 2001. Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype. J Biol Chem 276: 32022-32030.
40. Small D, Kovalenko D, Soldi R, Mandinova A, Kolev V, Trifonova R, Bagala C, Kacer D, Battelli C, Liaw L, Prudovsky I, Maciag T. 2003. Notch activation suppresses fibroblast growth factor-dependent cellular transformation. J Biol Chem 278: 16405-16413.
41. Soldi R, Mandinova A, Venkataraman K, Hla T, Vadas M, Pitson S, Duarte M, Graziani I, Kolev V, Kacer D, Kirov A, Maciag T, Prudovsky I. 2007. Sphingosine kinase 1 is a critical component of the copper-dependent FGF1 export pathway. Exp Cell Res 313: 3308-3318.
42. Thompson JA, Anderson KD, DiPietro JM, Zwiebel JA, Zametta M, Anderson WF, Maciag T. 1988. Site-directed neovessel formation in vivo. Science 241: 1349-1352.
43. Tomaszewski M, Charchar FJ, Lynch MD, Padmanabhan S, Wang WY, Miller WH, Grzeszczak W, Maric C, Zukowska-Szczechowska E, Dominiczak AF. 2007. Fibroblast growth factor 1 gene and hypertension: From the quantitative trait locus to positional analysis. Circulation 116: 1915-1924.
44. Woolley PV, Gollin SM, Riskalla W, Finkelstein S, Stefanik DF, Riskalla L, Swaney WP, Weisenthal L, McKenna RJ, Jr. 2000. Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes. Mol Diagn 5: 179-190.
45. Yu C, Wang F, Jin C, Huang X, Miller DL, Basilico C, McKeehan WL. 2003. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol 163: 1653-1662.
46. Zimrin AB, Villeponteau B, Maciag T. 1995. Models of in vitro angiogenesis: Endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem Biophys Res Commun 213: 630-638.